Breast cancer cells exploit iron for increased proliferation by enhancing iron uptake through transferrin receptor overexpression, suppressing iron export via ferroportin downregulation, and utilizing iron storage proteins such as ferritin to prevent oxidative damage. This evidence concerns the gene SLC40A1 and breast carcinoma.